Skip to main content
    A

    Amphastar P (AMPH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $29.17
    -0.20 (-0.68%)

    Market Cap: $1.25B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Amphastar P (AMPH) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Amphastar P are Eton Pharmaceuticals (ETON), Collegium Pharmaceutical (COLL) and Supernus Pharmaceuticals (SUPN). Amphastar P trades at 10.3x earnings, against a median of 12.7x for the 11 of these companies with a P/E. By market cap, Amphastar P ranks 9th of the 13 companies on this page; Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is the largest at $7.45B.

    Peer Comparison

    AMPH's ROIC of 7.9% is below the peer median of 11.6%, and its revenue growth of 8.2% is below the median of 13.3%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Amphastar P (AMPH)$1.25B10.3x1.7x13.3%7.9%8.2%0.00%
    Eton Pharmaceuticals Inc (ETON)$1.84B36.7x13.0x35.3%37.0%157.9%0.00%
    Collegium Pharmaceutical Inc (COLL)$786.83M3.7x1.0x4.7%8.1%3.3%0.00%
    Supernus Pharmaceuticals, Inc. (SUPN)$1.52B12.7x2.0x32.8%N/A13.4%0.00%
    Phibro Animal Health Corporation (PAHC)$1.46B10.7x0.9x6.7%11.7%6.3%1.37%
    Pacira BioSciences, Inc. (PCRX)$1.46B20.0x2.0x5.1%4.2%-1.6%0.00%
    BioCryst Pharmaceuticals Inc (BCRX)$1.96B4.4x2.0x-37.4%24937.1%13.1%0.00%
    Xeris Pharmaceuticals Inc (XERS)$3.04B139.2x8.2x-1.8%15.5%44.2%0.00%
    Prestige Brand Holdings Inc (PBH)$2.19B10.7x2.0x13.3%5.0%22.7%0.00%
    Ironwood Pharmaceuticals Inc (IRWD)$799.61M5.4x2.0x37.4%70.5%9.0%0.00%
    Harrow Health Inc (HROW)$1.13BN/A3.6x-9.4%-0.3%38.6%0.00%
    Cronos Group Inc (CRON)$1.24B28.4x5.6x28.0%N/A74.6%0.00%
    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)$7.45B21.4x2.2x4.2%11.6%10.0%0.00%
    Peer median$1.49B12.7x2.0x5.9%11.6%13.3%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Amphastar P, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Eton Pharmaceuticals Inc (ETON)
    Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases.
    ETON competitors
    Collegium Pharmaceutical Inc (COLL)
    Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications.
    COLL competitors
    Supernus Pharmaceuticals, Inc. (SUPN)
    Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of diseases...
    SUPN competitors
    Phibro Animal Health Corporation (PAHC)
    Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily...
    PAHC competitors
    Pacira BioSciences, Inc. (PCRX)
    Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United...
    PCRX competitors
    BioCryst Pharmaceuticals Inc (BCRX)
    BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
    BCRX competitors
    Xeris Pharmaceuticals Inc (XERS)
    Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations.
    XERS competitors
    Prestige Brand Holdings Inc (PBH)
    Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States...
    PBH competitors
    Ironwood Pharmaceuticals Inc (IRWD)
    Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products.
    IRWD competitors
    Harrow Health Inc (HROW)
    Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.
    HROW competitors
    Cronos Group Inc (CRON)
    Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
    CRON competitors
    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)
    Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms...
    AMRX competitors

    Frequently Asked Questions About AMPH

    Who are Amphastar P's main competitors?

    The companies most similar to Amphastar P include Eton Pharmaceuticals (ETON), Collegium Pharmaceutical (COLL), Supernus Pharmaceuticals (SUPN), Phibro Animal Health (PAHC) and Pacira BioSciences (PCRX), listed from the closest match.

    Who is Amphastar P's biggest competitor?

    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is the largest of the similar companies at $7.45B; Eton Pharmaceuticals (ETON) is the closest match by business profile, size, sector and industry.

    How does AMPH stock compare with its competitors?

    AMPH's P/E is 10.3x against a peer median of 12.7x; its P/S is 1.7x against a peer median of 2.0x; its net margin is 13.3% against a peer median of 5.9%.

    Which of Amphastar P's competitors pays a higher dividend?

    Amphastar P pays no dividend. Phibro Animal Health (PAHC) has a higher forward dividend yield; Phibro Animal Health (PAHC) has the highest at 1.37%.

    Is Amphastar P bigger than its competitors?

    No. Amphastar P is 9th by market cap among the 13 companies on this page; the largest is Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) at $7.45B.